Author:
Prawira A,Oosting S F,Chen T W,delos Santos K A,Saluja R,Wang L,Siu L L,Chan K K W,Hansen A R
Publisher
Springer Science and Business Media LLC
Reference70 articles.
1. Airoldi M, Pedani F, Marchionatti S, Gabriele AM, Succo G, Gabriele P, Bumma C (2002) Carboplatin plus taxol is an effective third-line regimen in recurrent undifferentiated nasopharyngeal carcinoma. Tumori 88: 273–276.
2. Altundag S, Gullu I, Altundag O, Ozyar E, Yalcin S, Cengiz M, Akyol F (2004) Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with Cisplatin-based chemotherapy. Med Oncol 21: 211–215.
3. Au EH, Ang PT (1998) Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer. Ann Oncol 9: 327–329.
4. Au PT (1994) A phase II trial of 5-fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma. Ann Oncol 5: 87–89.
5. Azli A, Bachouchi M, Rahal M, Lianes P, Wibault P, Boussen H, Eschwege F, Armand JP, Cvitkovic E (1995) Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type. Cancer J Sci Am 1: 222–229.
Cited by
75 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献